Sempere, A.; Egri, N.; Gonzalez, A.; Los-Arcos, I.; Marcos, M.A.; Bernal-Maurandi, J.; Ruiz-Cabrera, D.; Dieckmann, F.; Moreso, F.; Toapanta, N.;
et al. Utility of the ELISpot Test to Predict the Risk of Developing BK Polyomavirus Nephropathy in Kidney Recipients, a Multicenter Study. Vaccines 2025, 13, 796.
https://doi.org/10.3390/vaccines13080796
AMA Style
Sempere A, Egri N, Gonzalez A, Los-Arcos I, Marcos MA, Bernal-Maurandi J, Ruiz-Cabrera D, Dieckmann F, Moreso F, Toapanta N,
et al. Utility of the ELISpot Test to Predict the Risk of Developing BK Polyomavirus Nephropathy in Kidney Recipients, a Multicenter Study. Vaccines. 2025; 13(8):796.
https://doi.org/10.3390/vaccines13080796
Chicago/Turabian Style
Sempere, Abiu, Natalia Egri, Angela Gonzalez, Ibai Los-Arcos, MarÃa Angeles Marcos, Javier Bernal-Maurandi, Diana Ruiz-Cabrera, Fritz Dieckmann, Francesc Moreso, Néstor Toapanta,
and et al. 2025. "Utility of the ELISpot Test to Predict the Risk of Developing BK Polyomavirus Nephropathy in Kidney Recipients, a Multicenter Study" Vaccines 13, no. 8: 796.
https://doi.org/10.3390/vaccines13080796
APA Style
Sempere, A., Egri, N., Gonzalez, A., Los-Arcos, I., Marcos, M. A., Bernal-Maurandi, J., Ruiz-Cabrera, D., Dieckmann, F., Moreso, F., Toapanta, N., Pascal, M., & Bodro, M.
(2025). Utility of the ELISpot Test to Predict the Risk of Developing BK Polyomavirus Nephropathy in Kidney Recipients, a Multicenter Study. Vaccines, 13(8), 796.
https://doi.org/10.3390/vaccines13080796
